ANLN and prostate carcinoma: Through a genome-wide analysis of OCT1 target genes in AR-positive 22Rv1 cells, we identified a distinct set of target genes from LNCaP cells, including anillin-actin binding protein (ANLN) and discs large homolog-associated protein 5 (DLGAP5), that promotes cell cycle progression and proliferation in prostate cancer cells [15, 16].